These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7884705)

  • 1. Antisense DNA and RNA strategies: new approaches to therapy.
    Gibson I
    J R Coll Physicians Lond; 1994; 28(6):507-11. PubMed ID: 7884705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular therapeutic strategies in hepatitis B virus infection.
    Offensperger WB; Blum HE; Gerok W
    Clin Investig; 1994 Oct; 72(10):737-41. PubMed ID: 7865975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense technology for cancer therapy: does it make sense?
    Carter G; Lemoine NR
    Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis B virus by lentiviral vector delivered antisense RNA and hammerhead ribozymes.
    Nash KL; Alexander GJ; Lever AM
    J Viral Hepat; 2005 Jul; 12(4):346-56. PubMed ID: 15985004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense and sensibility.
    Dove A
    Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene therapeutic agents: the use of ribozymes, antisense, and RNA decoys for HIV-1 infection.
    Smythe JA; Symonds G
    Inflamm Res; 1995 Jan; 44(1):11-5. PubMed ID: 7664023
    [No Abstract]   [Full Text] [Related]  

  • 9. Antisense strategies in degenerative joint diseases: sense or nonsense?
    Huber LC; Distler O; Gay RE; Gay S
    Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of antisense technology in ophthalmology].
    Guo Y; Ge J
    Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.
    Lavrovsky Y; Chen S; Roy AK
    Biochem Mol Med; 1997 Oct; 62(1):11-22. PubMed ID: 9367793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hammerhead ribozymes: biochemical and chemical considerations.
    Goodchild J
    Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense DNA and RNA agents against picornaviruses.
    Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D
    Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of ribozymes in haematological disorders.
    James HA
    Expert Opin Investig Drugs; 2000 May; 9(5):1009-20. PubMed ID: 11060723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making sense of antisense.
    Murakami A
    Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
    [No Abstract]   [Full Text] [Related]  

  • 16. RNA as a target for developing antivirals.
    McKnight KL; Heinz BA
    Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense treatment of viral infection.
    Whitton JL
    Adv Virus Res; 1994; 44():267-303. PubMed ID: 7817875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.
    Rossi JJ; Sarver N
    Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448
    [No Abstract]   [Full Text] [Related]  

  • 20. Antisense principle or ribozyme action?
    Sczakiel G; Goody RS
    Biol Chem Hoppe Seyler; 1994 Nov; 375(11):745-6. PubMed ID: 7535059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.